BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 19476995)

  • 1. Neurofibromatosis type 2.
    Asthagiri AR; Parry DM; Butman JA; Kim HJ; Tsilou ET; Zhuang Z; Lonser RR
    Lancet; 2009 Jun; 373(9679):1974-86. PubMed ID: 19476995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
    Ruggieri M; Praticò AD; Evans DG
    Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited genetic syndromes and meningiomas.
    Look A; Lonser RR
    Handb Clin Neurol; 2020; 169():121-129. PubMed ID: 32553283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retinal Astrocytic Hamartoma in Neurofibromatosis Type 2 - Metaanalysis and a Case Report].
    Starosta DA; Lorenz B
    Klin Monbl Augenheilkd; 2018 Mar; 235(3):290-300. PubMed ID: 29534265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 2 (NF2): a clinical and molecular review.
    Evans DG
    Orphanet J Rare Dis; 2009 Jun; 4():16. PubMed ID: 19545378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.
    Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Di Mauro P; Licciardello L; Milone P; Privitera G; Belfiore G; Di Pietro M; Di Raimondo F; Romano A; Chiarenza A; Muglia M; Polizzi A; Evans DG
    Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):345-367. PubMed ID: 27958595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 2.
    Evans DG; Sainio M; Baser ME
    J Med Genet; 2000 Dec; 37(12):897-904. PubMed ID: 11106352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 2 (NF2): diagnosis and management.
    Lloyd SK; Evans DG
    Handb Clin Neurol; 2013; 115():957-67. PubMed ID: 23931824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.
    Parry DM; MacCollin MM; Kaiser-Kupfer MI; Pulaski K; Nicholson HS; Bolesta M; Eldridge R; Gusella JF
    Am J Hum Genet; 1996 Sep; 59(3):529-39. PubMed ID: 8751853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 2.
    Uppal S; Coatesworth AP
    Int J Clin Pract; 2003 Oct; 57(8):698-703. PubMed ID: 14627181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
    Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
    Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis type 2.
    Evans DG
    Handb Clin Neurol; 2015; 132():87-96. PubMed ID: 26564072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis type 2 appears to be a genetically homogeneous disease.
    Narod SA; Parry DM; Parboosingh J; Lenoir GM; Ruttledge M; Fischer G; Eldridge R; Martuza RL; Frontali M; Haines J
    Am J Hum Genet; 1992 Sep; 51(3):486-96. PubMed ID: 1496982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 2.
    Evans GR; Lloyd SKW; Ramsden RT
    Adv Otorhinolaryngol; 2011; 70():91-98. PubMed ID: 21358190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the neurofibromatosis type 2 gene in the development of tumors of the nervous system.
    Ruttledge MH; Rouleau GA
    Neurosurg Focus; 2005 Nov; 19(5):E6. PubMed ID: 16398470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia].
    Karwacki MW; Woźniak W
    Med Wieku Rozwoj; 2006; 10(3 Pt 2):923-48. PubMed ID: 17401183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
    Kley N; Seizinger BR
    Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.